TBPH 总资产历史(2016–2025)
THERAVANCE BIOPHARMA, INC. (TBPH) 各财年年末总资产(来自 SEC 财报)。
$485.6MFY2025 · FY2016 以来:$639.3M → $485.6M
| 财年 | 数值 | 同比 |
|---|---|---|
| FY2025 | $485.6M | +37.1% |
| FY2024 | $354.2M | -7.3% |
| FY2023 | $382.0M | -37.1% |
| FY2022 | $607.4M | +62.1% |
| FY2021 | $374.8M | -20.1% |
| FY2020 | $469.1M | +14.7% |
| FY2019 | $408.8M | -27.0% |
| FY2018 | $560.2M | +26.9% |
| FY2017 | $441.4M | -31.0% |
| FY2016 | $639.3M | — |
数据来自 SEC XBRL 申报 · 仅供参考 · 非投资建议